Bridging the gap between academic research and regulatory health risk assessment of endocrine disrupting chemicals

A Beronius, A Hanberg, J Zilliacus, C Rudén - Current opinion in …, 2014 - Elsevier
Highlights•The use of academic research in risk assessment of EDCs needs to be
improved.•Regulatory risk assessment puts specific requirements on study design and
reporting.•We review current methods for the evaluation of study adequacy and
reporting.•We highlight some critical study design aspects.•These measures aim to
contribute to better targeted policy decisions for chemicals.Regulatory risk assessment is
traditionally based primarily on toxicity studies conducted according to standardized and …
以上显示的是最相近的搜索结果。 查看全部搜索结果